Bone Solutions (BSI) received FDA 510(k) clearance for expanded indications for its Mg OSTEOINJECT, a drillable, adhesive and injectable bone void filler that incorporates magnesium, a critical component for bone health and development.
The expanded indication includes use of the material as an adjunct to hardware fixation by supporting the bone fragments during the surgical procedure. Magnesium-based Mg OSTEOINJECT has showed nearly 30% greater anchoring strength compared to traditional PMMA.
Mg OSTEOINJECT also provides a minimally invasive treatment option for insufficiency and micro fractures via percutaneous skeletal fixation. The adhesive properties and resorption profile of Mg OSTEOINJECT provide stability, increasing cell proliferation and advancing mineralization that to enhance bone regeneration in a broad range of orthopedic applications.
Mg OSTEOINJECT is currently distributed to facilities and surgical centers in the U.S.
Source: Bone Solutions Inc.
Bone Solutions (BSI) received FDA 510(k) clearance for expanded indications for its Mg OSTEOINJECT, a drillable, adhesive and injectable bone void filler that incorporates magnesium, a critical component for bone health and development.
The expanded indication includes use of the material as an adjunct to hardware fixation by supporting the bone...
Bone Solutions (BSI) received FDA 510(k) clearance for expanded indications for its Mg OSTEOINJECT, a drillable, adhesive and injectable bone void filler that incorporates magnesium, a critical component for bone health and development.
The expanded indication includes use of the material as an adjunct to hardware fixation by supporting the bone fragments during the surgical procedure. Magnesium-based Mg OSTEOINJECT has showed nearly 30% greater anchoring strength compared to traditional PMMA.
Mg OSTEOINJECT also provides a minimally invasive treatment option for insufficiency and micro fractures via percutaneous skeletal fixation. The adhesive properties and resorption profile of Mg OSTEOINJECT provide stability, increasing cell proliferation and advancing mineralization that to enhance bone regeneration in a broad range of orthopedic applications.
Mg OSTEOINJECT is currently distributed to facilities and surgical centers in the U.S.
Source: Bone Solutions Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.